XP0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Xenon Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 48.2 EUR -3.6% Market Closed

Market Cap: €1.4B

X	Xenon Pharmaceuticals Inc SWB:XP0	CA
M	Mantaro Precious Metals Corp OTC:MSLVF	CA
C	Commercial Metals Co XETRA:CMS	US
C	CompuGroup Medical SE & Co KgaA DUS:COP	DE

Profitability Summary

Xenon Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4 974%

Negative 3Y Average Operating Margin

-32 169%

Operating Margin is Increasing

-143 177% > -4 974%

Negative Net Margin

-4 612%

Negative 3Y Average Net Margin

-28 339%

Net Margin is Increasing

-125 938% > -4 612%

Negative Free Cash Flow Margin

-3 732%

Negative 3Y Average Free Cash Flow Margin

-23 696%

Free Cash Flow Margin is Increasing

-105 562% > -3 732%

Negative ROE

-52%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-173%

Declining ROIC

-251% > -304%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.